TARS

TARS: earnings, filings and news, read by Graham as they come out.

Reads

• The "substantial doubt" phrase appears in the historical audited financial statements of Alkeus Pharmaceuticals, Inc. (an acquired private company) for the fiscal year ended September 30, 2025, which were filed as an exhibit to Tarsus's Form 8-K/A, and does not represent a going-concern warning or a strategic fork for Tarsus Pharmaceuticals, Inc. itself. Dodd · TARS